Citations

Mayo Clinic

Clear

920 citation(s) found for "Yu, Cheng".

Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study (2328)
Silberstein, Stephen D., Zhang, Feng, Xue, Fei , Cheng, Sunfa , Chou, Denise E. , Ashina, Messoud , Goadsby, Peter J. , Reuter, Uwe , Dodick, David W. , Zhang, Feng, Lima, Gabriel Paiva da Silva

Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.96.15_supplement.2328 Get It

Long-term efficacy of erenumab in chronic migraine (CM) patients with or without acute medication overuse (AMO) (870)
Tepper, Stewart J. , Silberstein, Stephen D., Kudrow, David, Zhang, Feng, Cheng, Sunfa , Mikol, Daniel D., Lipton, Richard B. , Ashina, Messoud , Reuter, Uwe , Dodick, David W. , Zhang, Feng

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.870 Get It

Efficacy and Safety of Eculizumab in Patients with Neuromyelitis Optica Spectrum Disorder Previously Treated with Rituximab: Findings from the Phase 3 PREVENT Study (1788)
Kim, Ho Jin , Palace, Jacqueline , Terzi, Murat , Wang, Kaichen , Pace, Amy , Yountz, Marcus, Lawson, Diane, Meyer, Eva-Laudon , Wingerchuk, Dean M. , Levy, Michael , Berthele, Achim , Fujihara, Kazuo , Nakashima, Ichiro , Oreja‐Guevara, Celia , Pittock, Sean J. , Totolyan, N. А. , Viswanathan, Shanthi

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.1788 Get It

Impact of Eculizumab on Hospitalization Rates and Relapse Treatment in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: the Phase 3 PREVENT Study (1780)
Kim, Ho Jin , Palace, Jacqueline , Terzi, Murat , Wang, Kaichen , Pace, Amy, Fujita, Kenji P. , Yountz, Marcus, Armstrong, Róisín, Wingerchuk, Dean M. , Palace, Jacqueline , Palace, Jacqueline , Pittock, Sean J. , Berthele, Achim , Fujihara, Kazuo , Levy, Michael , Nakashima, Ichiro , Totolyan, N. А. , Viswanathan, Shanthi

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.1780 Get It

Impact of Eculizumab on Health Outcomes in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Findings from the PREVENT Study (1765)
Kim, Ho Jin , Palace, Jacqueline , Terzi, Murat , Wang, Kaichen , Shang, Shulian, Yountz, Marcus, Armstrong, Róisín, Wingerchuk, Dean M. , Palace, Jacqueline , Berthele, Achim , Pittock, Sean J. , Fujihara, Kazuo , Levy, Michael , Nakashima, Ichiro , Totolyan, N. А. , Viswanathan, Shanthi

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.1765 Get It

Impact of Eculizumab on Disability Worsening and Quality of Life in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Results from the Phase 3 PREVENT Study (1658)
Kim, Ho Jin , Terzi, Murat , Wang, Kaichen , Shang, Shulian, Yountz, Marcus, Armstrong, Róisín, Wingerchuk, Dean M. , Palace, Jacqueline , Pittock, Sean J. , Berthele, Achim , Fujihara, Kazuo , Levy, Michael , Nakashima, Ichiro , Totolyan, N. А. , Viswanathan, Shanthi

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.1658 Get It

Long-term Safety and Efficacy of Eculizumab in Neuromyelitis Optica Spectrum Disorder (1494)
Wingerchuk, Dean M. , Kim, Ho Jin , Palace, Jacqueline , Terzi, Murat , Wang, Kaichen , Allen, Kerstin , Fujita, Kenji P. , Yountz, Marcus, Armstrong, Róisín, Palace, Jacqueline , Pittock, Sean J. , Berthele, Achim , Fujihara, Kazuo , Levy, Michael , Nakashima, Ichiro , Totolyan, N. А. , Viswanathan, Shanthi

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.1494 Get It

Benefit of Eculizumab for a Broad Range of Patients with Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: Findings from the Phase 3 PREVENT Study (1299)
Kim, Ho Jin , Terzi, Murat , Wang, Kaichen , Pace, Amy , Yountz, Marcus, Miller, Larisa , Tanvir, Imran, Armstrong, Róisín, Wingerchuk, Dean M. , Fujihara, Kazuo , Berthele, Achim , Levy, Michael , Nakashima, Ichiro , Oreja‐Guevara, Celia , Palace, Jacqueline , Pittock, Sean J. , Totolyan, N. А. , Viswanathan, Shanthi

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.1299 Get It

Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+ Year Results of a 5-year, Open-label Treatment Period (1203)
Silberstein, Stephen D., Xue, Fei , Zhang, Feng, Cheng, Sunfa , Mikol, Daniel D., Ashina, Messoud , Goadsby, Peter J. , Reuter, Uwe , Dodick, David W. , Zhang, Feng

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.1203 Get It

Sirtuin 3 is down-regulated in Apolipoprotein E4 carriers with Alzheimer’s disease (P5.011)
Yin, Junxiang , Han, Peng Cheng, Caselli, Richard J. , Beach, Thomas G., Reiman, Eric M. , Shi, Jiong , Han, Pengcheng, Serrano, Geidy E.

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.p5.011 Get It